Immediate Impact
1 by Nobel laureates 6 from Science/Nature 67 standout
Citing Papers
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Works of Haby Henary being referenced
Targeting wild-type TP53 using AMG 232 in combination with MAPK inhibition in Metastatic Melanoma; a phase 1 study
2022
Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Haby Henary | 367 | 195 | 368 | 32 | 679 | |
| Christopher H. Chay | 309 | 183 | 329 | 24 | 723 | |
| Rama Krishna Kancha | 356 | 295 | 273 | 36 | 737 | |
| Carla Kurkjian | 295 | 156 | 474 | 41 | 812 | |
| Alessandra Bulotta | 393 | 237 | 257 | 46 | 668 | |
| Erwan Pencreach | 342 | 189 | 315 | 35 | 770 | |
| Tim N. Beck | 293 | 113 | 345 | 27 | 738 | |
| Weiming Duan | 323 | 149 | 403 | 39 | 800 | |
| B. Markman | 293 | 151 | 465 | 19 | 681 | |
| D. Fan | 358 | 168 | 401 | 23 | 796 | |
| Timothy Larson | 438 | 267 | 370 | 30 | 768 |
All Works
Loading papers...